Laurence H. Beck, MD, PhD
Associate Professor, Medicine
Biography
Laurence H. Beck, Jr., MD, PhD, completed his Internal Medicine residency and Nephrology fellowship at Boston Medical Center. He joined the Renal Section in 2006, and continues to conduct basic science research in the laboratory of Dr. David Salant on the pathogenesis of membranous nephropathy. His clinical roles include a weekly clinic and attending time on the consult and dialysis/transplant services. He also has expertise in immune-mediated glomerular disease.
Other Positions
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
- Graduate Faculty (Primary Mentor of Grad Students), Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences
Education
- Harvard Medical School, MD
- Harvard University, PhD
- Princeton University, BA
Publications
- Published on 6/21/2023
Beck LH, Ayoub I, Caster D, Choi MJ, Cobb J, Geetha D, Rheault MN, Wadhwani S, Yau T, Whittier WL. KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases. Am J Kidney Dis. 2023 Aug; 82(2):121-175. PMID: 37341661.
Read at: PubMed - Published on 12/29/2022
Al-Rabadi LF, Beck LH. Neuronal Proteins as Antigenic Targets in Membranous Nephropathy. Nephron. 2023; 147(8):451-457. PMID: 36580905.
Read at: PubMed - Published on 11/29/2022
Burbelo PD, Olson SW, Keller JM, Joshi M, Schwartz DM, Chuang YJ, Lambeau G, Beck LH, Waldman M. Prediagnostic Appearance of Thrombospondin Type-1 Domain 7A Autoantibodies in Membranous Nephropathy. Kidney360. 2023 Feb 01; 4(2):217-225. PMID: 36821613.
Read at: PubMed - Published on 9/29/2022
Sealfon R, Mariani L, Kretzler M, Beck LH. Authors' Reply: In Silico-Based Approach to the Discovery of New Antigens in Membranous Nephropathy. J Am Soc Nephrol. 2022 Dec; 33(12):2322-2323. PMID: 36175144.
Read at: PubMed - Published on 7/7/2022
Manral P, Caza TN, Storey AJ, Beck LH, Borza DB. The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy. Front Immunol. 2022; 13:952235. PMID: 35874690.
Read at: PubMed - Published on 4/27/2022
Sealfon R, Mariani L, Avila-Casado C, Nair V, Menon R, Funk J, Wong A, Lerner G, Hayashi N, Troyanskaya O, Kretzler M, Beck LH. Molecular Characterization of Membranous Nephropathy. J Am Soc Nephrol. 2022 Jun; 33(6):1208-1221. PMID: 35477557.
Read at: PubMed - Published on 1/1/2022
Kamel MH, Jaberi A, Gordon CE, Beck LH, Francis J. The Complement System in the Modern Era of Kidney Transplantation: Mechanisms of Injury and Targeted Therapies. Semin Nephrol. 2022 Jan; 42(1):14-28. PMID: 35618392.
Read at: PubMed - Published on 11/26/2021
Caza TN, Al-Rabadi LF, Beck LH. How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy. Front Immunol. 2021; 12:800242. PMID: 34899763.
Read at: PubMed - Published on 11/3/2021
Watts AJB, Keller KH, Lerner G, Rosales I, Collins AB, Sekulic M, Waikar SS, Chandraker A, Riella LV, Alexander MP, Troost JP, Chen J, Fermin D, Yee JL, Sampson MG, Beck LH, Henderson JM, Greka A, Rennke HG, Weins A. Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology. J Am Soc Nephrol. 2022 01; 33(1):238-252. PMID: 34732507.
Read at: PubMed - Published on 9/30/2021
Ronco P, Beck L, Debiec H, Fervenza FC, Hou FF, Jha V, Sethi S, Tong A, Vivarelli M, Wetzels J. Membranous nephropathy. Nat Rev Dis Primers. 2021 09 30; 7(1):69. PMID: 34593809.
Read at: PubMed
View 80 more publications: View full profile at BUMC